MASH/NASH
MASH/NASH
Lauren Dembeck, PhDMASH/NASH | July 28, 2025
Over half of T2DM patients in primary care have MASLD; over 10% of those with obesity may have advanced fibrosis.
Read More
Yvette C. TerrieMASH/NASH | July 25, 2025
Semaglutide improves liver health in MASH via weight loss and proteomic pathways, per a new Nature Medicine study.
Kaitlyn D’OnofrioMASH/NASH | April 12, 2023
Pediatric male patients with nonalcoholic fatty liver disease (NAFLD) could benefit from a diet low in free sugars, ...
Latest News
August 13, 2025